Compression Therapy Market To Reach $5.34 Billion By 2030

 

The global compression therapy market size is estimated to reach USD 5.34 billion by 2030, registering a CAGR of 3.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. Technological innovations resulting in the increasing adoption of compression therapy garments are the major factors driving the growth of the compression therapy market. In addition, the growing prevalence of venous and lymphatic diseases is leading to higher adoption of compression therapy products which is also driving the sales of the market.

For instance, according to the Lymphatic Education & Research Network, approximately 10 million Americans and hundreds of millions suffered from lymphedema and lymphatic diseases in 2022. The COVID-19 pandemic led to a rise in sales of compression therapy products with more people being hospitalized which led to an increase in the prevalence of venous disorders. Thus, resulting in a temporary rise in the sales of compression therapy products during the pandemic. However, a quick shift towards digital learning and an increasing inclination towards online work is resulting in lesser physical activities among individuals post the pandemic as well.

This in turn is leading to a larger section of the population being obese, creating a higher patient pool. As obese people are at a higher risk of developing chronic venous disorders. Thus, indicating a similar growth trend over the forecast period as well. Moreover, the growing government initiatives and increasing investments by key players in R&D are also expected to boost the growth of the compression therapy market over the forecast period. 

Request a free sample copy or view report summary: Compression Therapy Market Report

Compression Therapy Market Report Highlights

• The static compression therapy segment accounted for a higher market share in 2024, owing to the high convenience and user-friendly attributes of this technology.
• The dynamic compression therapy segment is expected to register the fastest CAGR, owing to the increasing recommendations of this technology by healthcare professionals.
• North America dominated the market with a revenue share of 42.43% in 2024, due to the increasing prevalence of chronic venous disorders, especially in the U.S.
• Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period, driven by several key factors, such as the increasing prevalence of chronic diseases, including venous disorders, lymphedema, and DVT, among the region's population.

Compression Therapy Market Segmentation

Grand View Research has segmented the global compression therapy market based on technology, end-use, distribution channel, and region:

Compression Therapy Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Static Compression Therapy
• Compression Bandages
• Compression Stockings
• Compression Tape
• Others Compression Garments
• Dynamic Compression Therapy
• Compression Pumps
• Compression Sleeves

Compression Therapy End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Specialty Clinics
• Home Healthcare
• Physician’s Office
• Nursing Homes
• Others

Compression Therapy Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Institutional Sales
• Retail Sales

Compression Therapy Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• Japan
• China
• India
• Australia
• Thailand
• South Korea
• Latin America
• Brazil
• Mexico
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

List of Key Players in the Compression Therapy Market

• Essity Aktiebolag (publ).
• Cardinal Health
• Julius Zorn GmbH
• Hartmann AG
• Medi GmbH & Co.
• SIGVARIS
• BSN Medical GmbH
• ArjoHuntleigh
• 3M Health Care
• Spectrum Healthcare
• Bio Compression Systems, Inc.
• Stryker
• Gottfried Medical
• Tactile Medical

 

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Vitrectomy Devices Market Size To Reach $1.87 Billion By 2030

 

The global Vitrectomy Devices Market size is expected to reach USD 1.87 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.3% from 2024 to 2030. The growing prevalence of diabetes is expected to drive the probability of diabetic retinopathy, thus, contributing to market growth. Additionally, the growing demand for vitrectomy due to its associated advantages for providing support to other ophthalmic surgeries is also expected to boost the market growth.

Ophthalmic diseases are seen prevalent in the elderly population. The growing geriatric population is expected to drive the market and the need for vitrectomy devices. As per the National Institute on Aging (NIA), the elderly population is expected to reach 72.0 million people by 2030, which may drive the prevalence of ophthalmic disorders. In addition to this, an increasing number of hospital admissions for retinal surgeries such as vitrectomy is expected to drive market growth. Moreover, hospitals have also installed vitrectomy devices to enhance vitreoretinal surgery procedures.

COVID-19 is expected to negatively impact the market in 2020. This is due to the reduction in medical setting visits for ophthalmic care to avoid the spread of infection. Additionally, people with COVID have to experience ophthalmic problems like conjunctivitis, which in turn, is causing hindrance among the medical professionals to perform general ophthalmic surgeries. However, the development of government guidelines to provide constant and effective medical care including ophthalmology may boost market growth during the forecast period.

The risks associated with vitrectomy are also expected to hinder the market growth. Patient undergone vitrectomy has a high probability of generating cataract after few years, thus, negatively impacting its adoption. Additionally, the lack of professional ophthalmologists to understand the operations of advanced vitrectomy devices with multiple functionalities may also pose a threat to the market.

Request a free sample copy or view report summary: Vitrectomy Devices Market Report

Vitrectomy Devices Market Report Highlights

• The vitrectomy machines held the largest revenue share in 2023 owing to the development of advanced machines with features such as small gauge size, and intraocular pressure control
• The vitrectomy packs segment is expected to grow at the fastest rate during the forecast period owing to its growing adoption for various indications
• The retinal detachment application segment is expected to grow at the fastest rate over the forecast period owing to the growing prevalence of high myopia. Patients with high myopia have a larger probability of developing retinal detachment
• The ambulatory surgical centers segment is expected to exhibit the highest growth rate during the forecast period due to its reduced costs and shorter wait time
• In Asia Pacific, the market is expected to grow at the highest rate due to the maximum cases of diabetic retinopathy in the region and the presence of a large patient pool

Vitrectomy Devices Market Segmentation

Grand View Research has segmented the global vitrectomy devices market based on product, application, end use, and region

Vitrectomy Devices Product Outlook (Revenue, USD Million, 2018 - 2030)

• Vitrectomy machines
• Vitrectomy packs
• Photocoagulation lasers
• Illumination devices

Vitrectomy Devices Application Outlook (Revenue, USD Million, 2018 - 2030)

• Diabetic retinopathy
• Retinal detachment
• Macular hole
• Vitreous hemorrhage
• Others

Vitrectomy Devices End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Ophthalmic clinics
• Ambulatory surgical centers

Vitrectomy Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• Japan
• China
• India
• Thailand
• South Korea
• Australia
• Latin America
• Brazil
• Argentina
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

List of Key Players of Vitrectomy Devices Market

• Alcon Inc.
• Bausch + Lomb.
• BVI
• NIDEK CO., LTD.
• Johnson & Johnson Vision Care, Inc.
• Blink Medical
• Topcon Corporation         
• Carl Zeiss Meditec AG
• HOYA Medical Singapore Pte. Ltd